養(yǎng)肝潤(rùn)目方治療肝腎虧虛型干眼臨床觀察

《養(yǎng)肝潤(rùn)目方治療肝腎虧虛型干眼臨床觀察》由會(huì)員上傳分享，免費(fèi)在線閱讀，更多相關(guān)內(nèi)容在應(yīng)用文檔-天天文庫(kù)。

1、養(yǎng)肝潤(rùn)目方治療肝腎虧虛型干眼臨床觀楊建芳(四川省資陽市雁江區(qū)中醫(yī)院四川資陽641300)目的：觀察養(yǎng)肝潤(rùn)目方治療肝腎虧虛型干眼的臨床療效。方法：將我院收治的86例肝腎虧虛型干眼癥患者隨機(jī)分為觀察組43例和對(duì)照組43例。對(duì)照組患者行淚然滴眼液治療，觀察組患者行養(yǎng)肝潤(rùn)目方治療。評(píng)價(jià)2組患者的臨床治療效果；治療前后，分別予以2組患者Schirmer試驗(yàn)檢測(cè)、淚膜破裂時(shí)間(BUT)檢測(cè)及角膜熒光素染色檢測(cè)；并隨訪觀察患者的復(fù)發(fā)率。結(jié)果：觀察組患者臨床治療的總有效率為90.70%，對(duì)照組為74.42%,2組比較，差異兵有統(tǒng)計(jì)學(xué)意義(P<0.05);治療后，

2、觀察組患者的平均Shirmer值與BUT值均高于對(duì)照組(P<0.05),平均角膜熒光素染色評(píng)分低于對(duì)照組(P<0.05)。6個(gè)月的觀察隨訪期間，觀察組患者的復(fù)發(fā)率為9.30%,對(duì)照組為18.60%,2組比較，差異具有統(tǒng)計(jì)學(xué)意義(P<0.05)。結(jié)論：養(yǎng)肝潤(rùn)目方治療肝腎虧虛型干眼的臨床療效顯著，能有效改善患者的淚液分泌量，提高淚膜的穩(wěn)定性，促進(jìn)角膜恢復(fù)，并降低復(fù)發(fā)率，值得臨床推廣與應(yīng)用。【關(guān)鍵詞】干眼癥；肝腎虧虛型；養(yǎng)肝潤(rùn)目方；淚然R692.5B1003-5028(2015)7-0151-02ObservationoftheNourishingan

3、dmoisturizingeyepartyclinicalcurativeeffectforthetreatmentofliverandkidneydeficiencytypeofdryeye【Abstract】objective:toobservetheNourishingandmoisturizingeyepartyclinicalcurativeeffectforthetreatmentofliverandkidneydeficiencytypeofdryeye.Methods:ourhospital’s86casesofliv

4、erandkidneydeficiencypatientswithdryeyesweredividedintotheobservationgroup(43cases)andthecontrolgroup(43cases).ThecontrolgrouppatientsweretreatedbyTearsNaturaleyedrops,theobservationgroupofpatientswastreatedbyNourishingandmoisturizingeyeparty.2groupsofpatientswiththeclinicalt

5、reatmenteffectwereevaluated;TheSchirmertestbeforeandaftertreatment,2groupsofpatients,itappearsrupturetime(BUT)andcornealfluoresceinstainingwasdetected;Inpatientswithrecurrenceratewasobserved.Results:observationgroupofpatientswithclinicaltreatmentthetotaleffectiveratewas90.70%

6、,controlgroupwas74.42%,thecomparisonoftwogroups,statisticallysignificantdifference(P<0.05);Aftertreatment,theobservationgroupofpatientswithanaverageShirmervaluewithBUTwerehigherthancontrolgroup(P<0.05),theaveragecornealfluoresceinstainingscoreswaslowerthanthecontrolgrou

7、p(P<0.05).During6monthsoffollow-upobservation,observationgroupofpatientswithrecurrenceratewas9.30%,thecontrolgroupwas18.60%,thecomparisonoftwogroups,statisticallysignificantdifference(P<0.05).Conclusion:aliverembellishtheeyeofthetreatmentofliverandkidneydeficiencytypedr

8、yeyeclinicalcurativeeffectisdistinct,caneffectivelyimprovepatienttea